Total Payments
$5,357
2024 Payments
$2,290
Companies
49
Transactions
215
Medicare Patients
1,855
Medicare Billing
$338,565
Payment Breakdown by Category
Food & Beverage$3,576 (66.7%)
Other$1,097 (20.5%)
Education$684.71 (12.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,576 | 195 | 66.7% |
| Long term medical supply or device loan | $1,097 | 11 | 20.5% |
| Education | $684.71 | 9 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,457 | 48 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $342.44 | 16 | $0 (2023) |
| PFIZER INC. | $322.54 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $285.89 | 11 | $0 (2024) |
| Amgen Inc. | $273.60 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $217.77 | 6 | $0 (2024) |
| Seagen Inc. | $216.50 | 10 | $0 (2023) |
| GENZYME CORPORATION | $197.29 | 10 | $0 (2024) |
| ABBVIE INC. | $172.91 | 5 | $0 (2024) |
| Kite Pharma, Inc. | $152.99 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,290 | 78 | Novartis Pharmaceuticals Corporation ($1,269) |
| 2023 | $1,276 | 74 | Novartis Pharmaceuticals Corporation ($143.01) |
| 2022 | $845.39 | 46 | E.R. Squibb & Sons, L.L.C. ($117.35) |
| 2021 | $212.57 | 3 | E.R. Squibb & Sons, L.L.C. ($100.99) |
| 2020 | $99.99 | 1 | Amgen Inc. ($99.99) |
| 2019 | $257.01 | 9 | AbbVie, Inc. ($99.95) |
| 2018 | $364.11 | 3 | Kite Pharma, Inc. ($125.00) |
| 2017 | $12.40 | 1 | The Medicines Company ($12.40) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/09/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $42.26 | General |
| Category: VTE | ||||||
| 11/06/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $28.22 | General |
| Category: Oncology | ||||||
| 10/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $3.77 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Oncology | ||||||
| 10/23/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Immunology | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Exelixis Inc. | — | Education | In-kind items and services | $99.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 628 | 1,485 | $347,307 | $127,270 |
| 2022 | 8 | 753 | 1,531 | $351,798 | $137,277 |
| 2021 | 9 | 428 | 743 | $168,266 | $69,756 |
| 2020 | 2 | 46 | 65 | $10,993 | $4,262 |
Total Patients
1,855
Total Services
3,824
Medicare Billing
$338,565
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 24 | 43 | $5,155 | $2,466 | 47.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 22 | 22 | $5,838 | $1,796 | 30.8% |
About Amit Bansal
Amit Bansal is a Internal Medicine healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1356736433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amit Bansal has received a total of $5,357 in payments from pharmaceutical and medical device companies, with $2,290 received in 2024. These payments were reported across 215 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($3,576).
As a Medicare-enrolled provider, Bansal has provided services to 1,855 Medicare beneficiaries, totaling 3,824 services with total Medicare billing of $338,565. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Troy, OH
- Active Since 04/05/2015
- Last Updated 04/16/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356736433
Products in Payments
- KISQALI (Drug) $1,210
- PADCEV (Biological) $269.75
- ELIQUIS (Drug) $172.08
- Blincyto (Biological) $158.92
- DARZALEX (Biological) $141.37
- Yescarta (Drug) $125.00
- IMBRUVICA (Drug) $123.44
- BEVYXXA (Drug) $116.05
- OPDIVO (Biological) $100.81
- Venclexta (Drug) $99.95
- TAZVERIK (Drug) $99.00
- Doptelet (Drug) $90.95
- JEVTANA (Drug) $88.99
- SARCLISA (Biological) $81.01
- IBRANCE (Drug) $73.91
- FLOWTRIEVER CATHETER, S (Device) $67.08
- KEYTRUDA (Biological) $62.53
- MONOFERRIC (Drug) $62.09
- XTANDI (Drug) $60.54
- ULTOMIRIS (Biological) $57.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Troy
Dr. Neil Fraser, Md, MD
Internal Medicine — Payments: $180,276
Internal Medicine $180,276
Dr. John Calado, Do, DO
Internal Medicine — Payments: $152,221
Internal Medicine $152,221
Michael Doyle, Md, MD
Internal Medicine — Payments: $85,884
Internal Medicine $85,884
Dr. Jay Sandberg, D.o, D.O
Internal Medicine — Payments: $28,867
Internal Medicine $28,867
Dr. Mohammed Kabir, Md, MD
Internal Medicine — Payments: $26,648
Internal Medicine $26,648
Dr. Noor Bunney, Md, MD
Internal Medicine — Payments: $21,394
Internal Medicine $21,394